Literature DB >> 3275820

Report of the organ transplant panel. Corneal transplantation. Council on Scientific Affairs.

.   

Abstract

Corneal transplantation is the most common form of organ transplantation practiced in the United States. Two procedures for transplantation are utilized. Penetrating keratoplasty is used in about 90% of the cases, with lamellar keratoplasty being utilized in the remaining situations. Demand for corneal transplantation exceeds the available supply of corneas. Advances in procurement and preservation must continue to meet this demand. Finally, these procedures are not without complications, and these are discussed to provide a clear risk-benefit analysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275820

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

Review 1.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells.

Authors:  Jian Wu; Yiqin Du; Simon C Watkins; James L Funderburgh; William R Wagner
Journal:  Biomaterials       Date:  2011-11-10       Impact factor: 12.479

Review 3.  Systemic cyclosporine and corneal transplantation.

Authors:  Mohammed Ziaei; Fatemeh Ziaei; Bita Manzouri
Journal:  Int Ophthalmol       Date:  2016-02       Impact factor: 2.031

4.  Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Authors:  Casey O Lightbourn; Dietlinde Wolf; Sabrina N Copsel; Ying Wang; Brent J Pfeiffer; Henry Barreras; Cameron S Bader; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

5.  Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.

Authors:  Pedram Hamrah; Satoru Yamagami; Ying Liu; Qiang Zhang; Sudhir S Vora; Bao Lu; Craig J Gerard; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

6.  Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).

Authors:  John Timothy Stout
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Optimizing rejection readouts in a corneal allograft transplantation model.

Authors:  Thabo Lapp; Antonia Hildebrand; Daniel Böhringer; Paola Kammrath Betancor; Günther Schlunck; Thomas Reinhard
Journal:  Mol Vis       Date:  2016-10-17       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.